BR112021001331A2 - uso de hidrocortisona ou um sal da mesma - Google Patents

uso de hidrocortisona ou um sal da mesma

Info

Publication number
BR112021001331A2
BR112021001331A2 BR112021001331A BR112021001331A BR112021001331A2 BR 112021001331 A2 BR112021001331 A2 BR 112021001331A2 BR 112021001331 A BR112021001331 A BR 112021001331A BR 112021001331 A BR112021001331 A BR 112021001331A BR 112021001331 A2 BR112021001331 A2 BR 112021001331A2
Authority
BR
Brazil
Prior art keywords
hydrocortisone
salt
treatment
epithelial
microbial
Prior art date
Application number
BR112021001331A
Other languages
English (en)
Inventor
Havrileck Bertrand
Mcgahie David
Jasmin Pierre
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of BR112021001331A2 publication Critical patent/BR112021001331A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

uso de hidrocortisona ou um sal da mesma . a presente invenção é dirigida a glicocorticoides para o tratamento de infecções microbianas epiteliais em órgão que contém fluido com um orifício exterior natural em mamíferos; esse novo uso terapêutico encontra particular interesse no tratamento de infecções microbianas epiteliais do ouvido (como otite externa), úbere (como mastite) e útero (como endometrite).
BR112021001331A 2018-07-30 2019-07-10 uso de hidrocortisona ou um sal da mesma BR112021001331A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306029.2A EP3603645B1 (en) 2018-07-30 2018-07-30 Novel use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals
PCT/EP2019/068619 WO2020025283A1 (en) 2018-07-30 2019-07-10 Novel use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals

Publications (1)

Publication Number Publication Date
BR112021001331A2 true BR112021001331A2 (pt) 2021-07-06

Family

ID=63144943

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021001331A BR112021001331A2 (pt) 2018-07-30 2019-07-10 uso de hidrocortisona ou um sal da mesma

Country Status (7)

Country Link
US (2) US11819506B2 (pt)
EP (2) EP3603645B1 (pt)
JP (2) JP7499750B2 (pt)
CN (1) CN112512528A (pt)
AU (1) AU2019315628A1 (pt)
BR (1) BR112021001331A2 (pt)
WO (1) WO2020025283A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023088308A1 (zh) * 2021-11-16 2023-05-25 石家庄迪斯凯威医药科技有限公司 一种具有抗耐药性的抗菌化合物
CN113855685A (zh) * 2021-11-18 2021-12-31 中国医学科学院基础医学研究所 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途
CN114404356A (zh) * 2022-01-18 2022-04-29 康膝生物医疗(深圳)有限公司 一种预防治疗奶牛子宫内膜炎的温敏型缓释载药凝胶制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585497B1 (en) 2002-12-16 2008-03-26 Intervet International BV Mastitis treatment with a combination of prednisolon and cephalosporin
BRPI0408556A (pt) 2003-03-20 2006-03-21 Pharmacia Corp formulações dispersìvel de um agente antiinflamatório
US8337481B2 (en) * 2005-01-25 2012-12-25 Patrick Slater Method for treating otitis externa
AU2007329708B2 (en) * 2006-12-01 2012-08-02 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
CN101439044B (zh) 2008-12-26 2010-12-01 华中农业大学 治疗奶牛乳腺炎的复方聚维酮碘凝胶及制备方法与在制药中的应用
WO2012085068A1 (en) * 2010-12-23 2012-06-28 Boehringer Ingelheim Vetmedica Gmbh Kit-in-parts for cleaning and treating ears of companion animals
TW201440768A (zh) * 2013-02-27 2014-11-01 Almirall Sa 雙毒蕈鹼拮抗劑-β2腎上腺素促效劑複合物及皮質類固醇之組合物
US20170042916A1 (en) * 2014-05-19 2017-02-16 Carl Hilliard Animal tissue colonization and treatment of infection
US20170304409A1 (en) * 2014-09-24 2017-10-26 ISTITUTO PROFILATTICO E FARMACEUTICO CANDIOLI & C. SPA in abbreviated form CANDIOLI FARMACEUTICI Compositions useful for the prevention and/or treatment of infections and inflammations

Also Published As

Publication number Publication date
AU2019315628A1 (en) 2021-02-25
EP3603645B1 (en) 2024-08-07
JP7499750B2 (ja) 2024-06-14
EP3829591A1 (en) 2021-06-09
WO2020025283A1 (en) 2020-02-06
EP3603645A1 (en) 2020-02-05
US20240016818A1 (en) 2024-01-18
EP3603645C0 (en) 2024-08-07
US11819506B2 (en) 2023-11-21
CN112512528A (zh) 2021-03-16
US20220008439A1 (en) 2022-01-13
JP2021533099A (ja) 2021-12-02
JP2024113041A (ja) 2024-08-21

Similar Documents

Publication Publication Date Title
BR112021001331A2 (pt) uso de hidrocortisona ou um sal da mesma
AR118171A1 (es) Preparaciones de membrana bacteriana
BR112019016497A2 (pt) 2-heteroaril-3-oxo-2,3-di-hidropiridazina-4-carboxamidas para o tratamento de câncer.
BR112015020302A2 (pt) derivado de pirazol
TWD215802S (zh) 鼻管組合
BR112018074185A2 (pt) 3-oxo-2,6-difenil-2,3-di-hidropiridazina-4-carboxamidas
TWD204242S (zh) Ｇｐｓ裝置
CL2018002516A1 (es) Inhibidores de mcl-1 indólicos sustituidos.
MX2019007116A (es) Registro adaptativo de imágenes para cirugia oftalmica.
CO2018011701A2 (es) Formulaciones de antibióticos glicopeptídicos estabilizados
BR112017004141A2 (pt) ?sondas para imageamento de proteína de huntingtina?
BR112015030399B8 (pt) Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3
BR112012012529A2 (pt) composto indol e seu uso farmacêutico
DOP2019000275A (es) Nuevos derivados de pirazol bicíclicos
BR112018075736A2 (pt) composto de amida alfa e beta insaturado derivado de benzotriazol usado como inibidor de tgf-betar1
CL2020000050A1 (es) Compuestos que afectan la producción de pigmentos y su uso para el tratamiento de enfermedades bacterianas.
BR112019001193A2 (pt) uso de sulfatos de colesterol oxigenados (ocs) para tratar doença de pele inflamatória e lesões de pele
CL2021002819A1 (es) Una vacuna de subunidad para el tratamiento o la prevención de una infección del tracto respiratorio
BR112018003331A2 (pt) sondas para imagear proteína huntingtina
BR112019025030A2 (pt) Preparação umidificante tópica.
BR112019024549A2 (pt) compostos derivados de glicopeptídeo e usos dos mesmos
BR112021024716A2 (pt) Ruptura de biofilme
BR112021018815A2 (pt) Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário
BR102018068947A8 (pt) sistemas de instrumento cirúrgico ortopédico específicos para um lado do corpo e métodos de uso associados
BR112012024999A2 (pt) combinação e uso